Comparison between Cultivated Oral Mucosa and Ocular Surface Epithelia for COMET Patients Follow-Up

Author:

Attico Eustachio1ORCID,Galaverni Giulia1ORCID,Torello Andrea12,Bianchi Elisa1ORCID,Bonacorsi Susanna1,Losi Lorena3,Manfredini Rossella1ORCID,Lambiase Alessandro4ORCID,Rama Paolo5,Pellegrini Graziella12

Affiliation:

1. Centre for Regenerative Medicine “Stefano Ferrari”, University of Modena and Reggio Emilia, 41125 Modena, Italy

2. Holostem Terapie Avanzate s.r.l., 41125 Modena, Italy

3. Unit of Pathology, Department of Life Sciences, University of Modena and Reggio Emilia, 41124 Modena, Italy

4. Department of Sense Organs, Sapienza University of Rome, 00169 Rome, Italy

5. SC Ophathalmology, IRCCS Policlinico San Matteo Foundation, 27100 Pavia, Italy

Abstract

Total bilateral Limbal Stem Cell Deficiency is a pathologic condition of the ocular surface due to the loss of corneal stem cells. Cultivated oral mucosa epithelial transplantation (COMET) is the only autologous successful treatment for this pathology in clinical application, although abnormal peripheric corneal vascularization often occurs. Properly characterizing the regenerated ocular surface is needed for a reliable follow-up. So far, the univocal identification of transplanted oral mucosa has been challenging. Previously proposed markers were shown to be co-expressed by different ocular surface epithelia in a homeostatic or perturbated environment. In this study, we compared the transcriptome profile of human oral mucosa, limbal and conjunctival cultured holoclones, identifying Paired Like Homeodomain 2 (PITX2) as a new marker that univocally distinguishes the transplanted oral tissue from the other epithelia. We validated PITX2 at RNA and protein levels to investigate 10-year follow-up corneal samples derived from a COMET-treated aniridic patient. Moreover, we found novel angiogenesis-related factors that were differentially expressed in the three epithelia and instrumental in explaining the neovascularization in COMET-treated patients. These results will support the follow-up analysis of patients transplanted with oral mucosa and provide new tools to understand the regeneration mechanism of transplanted corneas.

Funder

Awards “Lombardia è Ricerca 2018”

“Louis Jeantet Award 2020”

Holostem Terapie Avanzate s.r.l.

Regione Emilia-Romagna

POR-FESR

Publisher

MDPI AG

Subject

Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis

Reference80 articles.

1. Stem cells and ocular regeneration;Chiavelli;Encyclopedia of Tissue Engineering and Regenerative Medicine,2019

2. Presentation, Diagnosis and Management of Limbal Stem Cell Deficiency;Sejpal;Middle East Afr. J. Ophthalmol.,2013

3. Global Consensus on Definition, Classification, Diagnosis, and Staging of Limbal Stem Cell Deficiency;Deng;Cornea,2019

4. Education for the translation of Advanced Therapy Medicinal Products;Adamo;Front. Med.,2023

5. Navigating Market Authorization: The Path Holoclar Took to Become the First Stem Cell Product Approved in the European Union;Pellegrini;Stem Cells Transl. Med.,2018

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3